<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2014.3695</article-id>
<article-id pub-id-type="publisher-id">or-33-03-1185</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1&#x003B1; signaling under hypoxia</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>SHI</surname><given-names>HENGLIANG</given-names></name><xref rid="af1-or-33-03-1185" ref-type="aff">1</xref><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref><xref rid="fn1-or-33-03-1185" ref-type="author-notes">*</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHENG</surname><given-names>BAO</given-names></name><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref><xref rid="fn1-or-33-03-1185" ref-type="author-notes">*</xref></contrib>
<contrib contrib-type="author">
<name><surname>WU</surname><given-names>YUXUAN</given-names></name><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>TANG</surname><given-names>YUAN</given-names></name><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>LEI</given-names></name><xref rid="af1-or-33-03-1185" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>GAO</surname><given-names>YONG</given-names></name><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>GONG</surname><given-names>HUI</given-names></name><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>DU</surname><given-names>JIN</given-names></name><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>YU</surname><given-names>RUTONG</given-names></name><xref rid="af1-or-33-03-1185" ref-type="aff">1</xref><xref rid="af2-or-33-03-1185" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-or-33-03-1185"/></contrib></contrib-group>
<aff id="af1-or-33-03-1185">
<label>1</label>Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, P.R. China</aff>
<aff id="af2-or-33-03-1185">
<label>2</label>The Graduate School, Xuzhou Medical College, Xuzhou, Jiangsu, P.R. China</aff>
<author-notes>
<corresp id="c1-or-33-03-1185">Correspondence to: Dr Rutong Yu, Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical College, 99 West Huaihai Road, Xuzhou, Jiangsu 221002, P.R. China, E-mail: <email>yu.rutong@163.com</email></corresp><fn id="fn1-or-33-03-1185">
<label>*</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>12</month>
<year>2014</year></pub-date>
<volume>33</volume>
<issue>3</issue>
<fpage>1185</fpage>
<lpage>1190</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>10</month>
<year>2014</year></date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2015, Spandidos Publications</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>It has been reported that by regulating PHD3 stability, Siah1 contributes to the abundance of hypoxia-inducible factor (HIF)-1&#x003B1;, thereby playing an important role in the cellular response to hypoxia. However, the expression level and functional significance of Siah1 in human malignant glioma, which is characterized by high migration and invasion potential, have never been investigated. We report here, that Siah1 was expressed highly in human glioma tissues compared with its expression in normal brain tissues and was correlated with advanced tumor status and stage. The knockdown of Siah1 by short-hairpin RNA severely suppressed the migration and invasion of human glioma U251 cells under hypoxia, while overexpression of Siah1 promoted it. Furthermore, we demonstrated that the glioma cell migration and invasion under hypoxia mediated by Siah1 was achieved by reducing the stability of PHD3, which protected the HIF-1&#x003B1; from degradation. These findings suggest that Siah1 plays important roles in the migration and invasion of human glioma cells under hypoxia, which may provide some guidance for the targeted therapy of human glioma based on the interference of the Siah1-PHD3-HIF-1&#x003B1; signaling pathway.</p></abstract>
<kwd-group>
<kwd>Siah1</kwd>
<kwd>PHD3</kwd>
<kwd>HIF-1&#x003B1;</kwd>
<kwd>hypoxia</kwd>
<kwd>glioma</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Glioblastoma multiforme (GBM) is the most common and malignant primary tumor that develops in the central nervous system. Despite advances in surgery and adjuvant therapy, the overall 5-year survival rate of GBM remains less than 5&#x00025; and is even worse for elderly patients due to the highly invasive ability of these cancer cells (<xref rid="b1-or-33-03-1185" ref-type="bibr">1</xref>,<xref rid="b2-or-33-03-1185" ref-type="bibr">2</xref>).</p>
<p>Hypoxia-inducible factor 1&#x003B1; (HIF-1&#x003B1;) and hypoxia-responsive genes play important roles in glioma migration and invasion (<xref rid="b3-or-33-03-1185" ref-type="bibr">3</xref>&#x02013;<xref rid="b5-or-33-03-1185" ref-type="bibr">5</xref>). Hypoxia is important in the biology and aggression of human glial brain tumors (<xref rid="b6-or-33-03-1185" ref-type="bibr">6</xref>,<xref rid="b7-or-33-03-1185" ref-type="bibr">7</xref>). Although HIF-1&#x003B1; is maintained at a low level in normoxic cells due to the degradation mediated by the proteasome (<xref rid="b8-or-33-03-1185" ref-type="bibr">8</xref>), it plays a critical role in the cellular response to tumor hypoxia, which may be a major obstacle to the killing of cancer cells by radiotherapy and chemotherapy (<xref rid="b6-or-33-03-1185" ref-type="bibr">6</xref>). It has been reported that HIF-1&#x003B1; is upregulated in a variety of human cancers, including prostate (<xref rid="b9-or-33-03-1185" ref-type="bibr">9</xref>), breast (<xref rid="b10-or-33-03-1185" ref-type="bibr">10</xref>) and glioma (<xref rid="b3-or-33-03-1185" ref-type="bibr">3</xref>). Inhibition of HIF-1&#x003B1; expression with antisense oligonucleotides was found to decrease the survival of glioblastoma cells and induce p53-independent apoptosis (<xref rid="b11-or-33-03-1185" ref-type="bibr">11</xref>). Moreover, silencing of HIF-1&#x003B1; by RNA interference reduced human glioma migration and invasion (<xref rid="b12-or-33-03-1185" ref-type="bibr">12</xref>,<xref rid="b13-or-33-03-1185" ref-type="bibr">13</xref>). Although the function of HIF-1&#x003B1; has been widely studied under hypoxic stress, the mechanism regulating the activation of HIF-1&#x003B1; is still unclear, and should be further understood for designing more effective therapeutic strategies.</p>
<p>The protein seven in absentia (SINA) was firstly discovered in R7 cells, and functions in the cell fate in the <italic>Drosophila</italic> eye (<xref rid="b14-or-33-03-1185" ref-type="bibr">14</xref>). Two homologs of the SINA gene have been identified in humans, Siah1 and Siah2 (<xref rid="b15-or-33-03-1185" ref-type="bibr">15</xref>). Siah1 and Siah2 have been shown to dominate the stability of several substrates, including nuclear corepressor, &#x003B2;-catenin, TRAF2, &#x003B1;-ketoglutarate dehydrogenase and prolyl hydroxylase 3 (PHD3), thereby affecting diverse cellular processes, such as signaling, survival and mitochondrial biogenesis (<xref rid="b16-or-33-03-1185" ref-type="bibr">16</xref>&#x02013;<xref rid="b20-or-33-03-1185" ref-type="bibr">20</xref>). In addition to the physiological function, Siah1 is found to be involved in several types of cancer. It has been reported that Siah1 plays a role as a tumor suppressor in hepatocellular carcinomas and breast cancer (<xref rid="b21-or-33-03-1185" ref-type="bibr">21</xref>,<xref rid="b22-or-33-03-1185" ref-type="bibr">22</xref>). However, in nasopharyngeal carcinoma, Siah1 has been reported as an oncogene and is significantly correlated with advanced tumor status and stage (<xref rid="b23-or-33-03-1185" ref-type="bibr">23</xref>). To date, the role of Siah1 in human glioma has not been elucidated.</p>
<p>In the present study, we investigated the role and intracellular signaling pathway of Siah1 in the aggressive behavior of glioma under hypoxic stress. We found that Siah1 levels in glioma tissues were significantly upregulated, suggesting a potential role of this protein in the progression of gliomas. Then, we observed that the knockdown of Siah1 inhibited the migration and invasion of human glioma cells under hypoxia, while overexpression of Siah1 promoted it. Furthermore, we demonstrated that the Siah1-regulated migration and invasion of human glioma cells under hypoxia were mediated by decreasing the stability of PHD3, thereby stabilizing the HIF-1&#x003B1;.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Tissue samples</title>
<p>Six specimens of non-tumorous brain tissues (internal decompression in cerebral trauma) and 16 specimens of glioma tissues were obtained from the Affiliated Hospital of Xuzhou Medical College (Xuzhou, China). Surgically removed tissues were sampled for histological diagnosis, and the remaining tissues were immediately frozen in liquid nitrogen and stored at &#x02212;80&#x000B0;C. The present study was approved by the Research Ethics Committee of Xuzhou Medical College, and informed consent was provided by the patients.</p></sec>
<sec>
<title>Cell culture</title>
<p>Cell lines (293T and U251) were purchased from the Cell Bank of the Shanghai Institutes of the Chinese Academy of Sciences and were cultured in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM; Invitrogen, Carlsbad, CA, USA) supplemented with 10&#x00025; fetal bovine serum (FBS; Evergreen Biological Engineering Co., Hangzhou, China) at 37&#x000B0;C in 5&#x00025; CO<sub>2</sub>. For hypoxia, the cells were cultured in a modular incubator chamber (150i; Thermo Fisher Scientific, Waltham, MA, USA) at 37&#x000B0;C with 5&#x00025; CO<sub>2</sub>, 1&#x00025; O<sub>2</sub> and 94&#x00025; N<sub>2</sub>.</p></sec>
<sec>
<title>Constructs and production of the lentivirus</title>
<p>For overexpression of Siah1, the Siah1 cDNA was inserted into the pWPXLd plasmid using <italic>Bam</italic>HI and <italic>Mlu</italic>I sites. For silencing of Siah1, two short hairpin RNA (shRNA) duplexes were designed as follows: shSiah1A F, TGATAGGAACACGCAAGCAATTCAAGAGATTGCTTGCGTGTTCCTATCTTTTTTC and shSiah1A R, TCGAGAAAAAAGATAGGAACACGCAAGCAATCTCTTGAATTGCTTGCGTGTTCCTATCA; shSiah1B F, TCACACCTTTGAGCTTAATCTTCAAGAGAGATTAAGCTCAAAGGTGTGTTTTTTC and shSiah1B R, TCGAGAAAAAACACACCTTTGAGCTTAATCTCTCTTGAAGATTAAGCTCAAAGGTGTGA. The shRNA oligomers and non-targeting oligomers (scramble) were annealed and then subcloned into the pLL3.7 plasmid by the <italic>Hpa</italic>I and <italic>Xho</italic>I cloning site. Cell transfection was performed with PolyJET (SignaGen, Gaithersburg, MD, USA) as described in the manufacturer&#x02019;s protocol. The viruses were propagated in 293T cells by cotransfecting the corresponding plasmids with the helper plasmids.</p></sec>
<sec>
<title>Establishment of the stable cell lines</title>
<p>The formation of the stable cell lines was previously described (<xref rid="b24-or-33-03-1185" ref-type="bibr">24</xref>). For stable overexpression of Siah1, the U251 cells were infected by GFP or GFP-Siah1 viruses, respectively. Forty-eight hours after infection, the cells were continuously cultured in medium containing 2.5 &#x003BC;g/ml puromycin (Sigma, St. Louis, MO, USA). The surviving cells were cultured into cell lines stably expressing GFP or GFP-Siah1. For the silencing of Siah1, the scramble or shSiah1 virus-infected U251 cells were subjected to the sorting of GFP-positive cells by flow cytometry. GFP-positive cells were cultured to produce stable lines silenced for Siah1.</p></sec>
<sec>
<title>Western blotting</title>
<p>Equal amounts of protein lysates were subjected to 10&#x00025; SDS-PAGE and then transferred to a PVDF membrane (Millipore, Billerica, MA, USA) and probed with the primary antibodies (Siah1, PHD3, HIF-1&#x003B1;, &#x003B2;-actin) at 4&#x000B0;C overnight and the secondary antibodies at room temperature for 1 h. Bound antibodies were detected by the ECL Plus Western Blotting Substrate (Thermo Fisher, Waltham, MA, USA) and exposed to X-ray film. Band densities were quantified by ImageJ software. The relative amount of the proteins was determined by normalization of the densitometry.</p></sec>
<sec>
<title>Wound healing assay</title>
<p>The stable cell lines were cultured in a 6-well plate under normal conditions for 24 h and starved by no serum for 12 h. Then, scratches were performed in the middle of the wells with a pipette tip. Thereafter, the cells were cultured under a hypoxic condition (5&#x00025; CO<sub>2</sub>, 1&#x00025; O<sub>2</sub> and 94&#x00025; N<sub>2</sub>) for 12 and 24 h. The images were captured by an inverted microscope (IX71; Olympus, Tokyo, Japan) at the designated time points. The number of cells crossing the wound was normalized according to the control.</p></sec>
<sec>
<title>Invasion assay</title>
<p>Cell invasion was assessed using Matrigel-precoated Transwell inserts (8.0-&#x003BC;m pore size with polyethylene tetraphthalate membrane; Invitrogen) according to the manufacturer&#x02019;s protocol. The pretreated cell suspension (1&#x000D7;10<sup>5</sup>) in serum-free culture media was added into the inserts, and each insert was placed in the lower chamber filled with culture media containing 10&#x00025; FBS as a chemoattractant. The invasion chambers were incubated under a hypoxic condition for 24 h. Then, the non-invasive cells were removed from the upper chamber; filters were fixed with methanol for 15 min and stained with a 0.1&#x00025; crystal violet solution for 10 min. Five fields of adherent cells in each well were randomly photographed under an inverted microscope and counted.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Data are presented as the means &#x000B1; SEM. Statistical significance was determined using the Student&#x02019;s t-test, and P&lt;0.05 was considered to indicate a statistically significant result.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Siah1 is expressed increasingly in human glioma tissues</title>
<p>In order to understand the possible role of Siah1 in human glioma, we examined the Siah1 expression in 6 specimens of non-tumorous brain tissues and 18 specimens of glioma tissues (6 low-grade and 12 high-grade) by western blotting. A representative blot is shown in <xref rid="f1-or-33-03-1185" ref-type="fig">Fig. 1A</xref>. The statistical results indicated that the protein level of Siah1 in the glioma tissues was higher than that in the non-tumorous tissues and was correlated with advanced tumor status and stage (<xref rid="f1-or-33-03-1185" ref-type="fig">Fig. 1A and B</xref>). These results suggest that Siah1 expression is upregulated in human glioma, which provides us with initial evidence that Siah1 plays a role in the development and progression of human glioma.</p></sec>
<sec>
<title>Downregulation of Siah1 inhibits glioma cell migration and invasion under hypoxia</title>
<p>To investigate the possible role of Siah1 in the development and progression of human glioma, we utilized loss-of- and gain-of function approaches. Firstly, we downregulated Siah1 expression using its specific short hairpin RNA and observed the effects on cell migration and invasion. For the silencing of Siah1, two shRNA targets (shSiah1A and shSiah1B) were cloned into the lentiviral vector pLL3.7 and screened for their efficacy in suppressing Siah1 expression, and a negative control shRNA (scramble) was used as a control. As shown in <xref rid="f2-or-33-03-1185" ref-type="fig">Fig. 2A</xref>, the silencing efficiency of shSiah1B was ~80&#x00025;. Thereafter, shSiah1B and the scramble were packaged into the lentivirus in 293T cells and used to establish the stable cell line with loss of Siah1 (<xref rid="f2-or-33-03-1185" ref-type="fig">Fig. 2B</xref>). Next, we investigated whether the cell migration and invasion were affected by the silencing of Siah1 under hypoxia in the stable cell lines. The wound healing assay showed that the number of migratory cells was reduced by 27 and 36&#x00025; at 12 and 24 h (<xref rid="f2-or-33-03-1185" ref-type="fig">Fig. 2C and D</xref>). The Transwell assay showed that the invasive cells decreased by 43&#x00025;, compared with the corresponding controls (<xref rid="f2-or-33-03-1185" ref-type="fig">Fig. 2E and F</xref>). These results indicate that Siah1 is involved in the migration and invasion of human glioma cells and downregulation of Siah1 inhibits the glioma cell migration and invasion under hypoxia.</p></sec>
<sec>
<title>Overexpression of Siah1 promotes glioma cell migration and invasion under hypoxia</title>
<p>To further investigate the role of Siah1, we tested the effect of Siah1 on cell migration and invasion in U251 cells transfected by a lentivirus overexpressing Siah1. The stable cell lines overexpressing GFP or GFP-Siah1 were assessed by GFP imaging and western blotting (<xref rid="f3-or-33-03-1185" ref-type="fig">Fig. 3A and B</xref>). Then, we investigated whether the cell migration and invasion were promoted upon Siah1 overexpression under hypoxia in the stable lines expressing GFP or GFP-Siah1. The wound healing assay showed that the number of migratory cells was increased by 25 and 62&#x00025; at 12 and 24 h (<xref rid="f3-or-33-03-1185" ref-type="fig">Fig. 3C and D</xref>) and the Transwell assay showed that the number of invasive cells increased by 51&#x00025;, when compared with the corresponding controls (<xref rid="f2-or-33-03-1185" ref-type="fig">Fig. 2E and F</xref>). These results further indicate that Siah1 is involved in the migration and invasion of human glioma cells, and overexpression of Siah1 promotes glioma cell migration and invasion under hypoxia.</p></sec>
<sec>
<title>Siah1 induces HIF-1&#x003B1; by promoting the degradation of PHD3 in human glioma cells under hypoxia</title>
<p>It has been reported that HIF-1&#x003B1; is activated under hypoxia and plays a crucial role in glioma cell migration and invasion (<xref rid="b3-or-33-03-1185" ref-type="bibr">3</xref>); however, whether Siah1 is involved in the regulation of HIF-1&#x003B1; in human glioma cells is still unclear. For this reason, we detected the expression level of PHD3 and HIF-1&#x003B1; in Siah1 loss-of- and gain-of-function studies at several hypoxia time points by western blotting. We found that loss of Siah1 led to a more rapid increase in oxygen sensor PHD3 thereby inhibiting the production of HIF-1&#x003B1; when compared with the control (<xref rid="f4-or-33-03-1185" ref-type="fig">Fig. 4A and B</xref>). In addition, we analyzed the role of Siah1 under the condition of overexpression. As shown in <xref rid="f4-or-33-03-1185" ref-type="fig">Fig. 4C and D</xref>, compared with the control, overexpression of Siah1 resulted in a slower increase in PHD3 thereby promoting the rapid production of HIF-1&#x003B1;. These results suggest that Siah1 promotes cell migration and invasion by regulating the degradation of PHD3 thereby improving the stability of HIF-1&#x003B1;.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, we showed that Siah1 contributes to glioma cell migration and invasion by reducing the stability of PHD3, thereby stabilizing HIF-1&#x003B1;. The following results support our conclusion. Firstly, the western blotting results showed that Siah1 was upregulated in the human glioma tissues. Secondly, downregulation of Siah1 suppressed glioma cell migration and invasion while Siah1 overexpression promoted it. Thirdly, downregulation of Siah1 stabilized PHD3 and attenuated the production of HIF-1&#x003B1; under hypoxia, while overexpression of Siah1 reduced the stability of PHD3 and accelerated the production of HIF-1&#x003B1;.</p>
<p>Hypoxia is one of the important features of human glioblastoma, which is associated with poor prognosis, increased angiogenesis, tumor growth and resistance to radiotherapy and chemotherapy (<xref rid="b12-or-33-03-1185" ref-type="bibr">12</xref>). HIF-1&#x003B1;, a pivotal hypoxia regulatory factor, has been shown to promote both angiogenesis and invasion. Upregulation of HIF-1&#x003B1; is an important physiological process of glioma adaptation to hypoxia (<xref rid="b25-or-33-03-1185" ref-type="bibr">25</xref>). Our data showed that, when glioma cells were in a hypoxic condition, downregulation of Siah1 inhibited the production of HIF-1&#x003B1; while overexpression of Siah1 promoted it. These data support that Siah1 plays an important role in the regulation of HIF-1&#x003B1; under hypoxia and that inhibition of Siah1 may be an attractive therapeutic strategy by which to target the tumor microenvironment.</p>
<p>Although the role of HIF-1&#x003B1; in glioma cell progression has been well studied (<xref rid="b3-or-33-03-1185" ref-type="bibr">3</xref>,<xref rid="b6-or-33-03-1185" ref-type="bibr">6</xref>,<xref rid="b11-or-33-03-1185" ref-type="bibr">11</xref>&#x02013;<xref rid="b13-or-33-03-1185" ref-type="bibr">13</xref>), the regulatory mechanism to date remains unclear. It has been demonstrated that Rho small GTPases, Myc, mTOR and protein prenylation transferase GGTI are involved in regulating HIF-1&#x003B1; induction (<xref rid="b26-or-33-03-1185" ref-type="bibr">26</xref>&#x02013;<xref rid="b31-or-33-03-1185" ref-type="bibr">31</xref>). Particularly, it has been reported that ubiquitin ligase Siah2 contributes to the abundance of HIF-1&#x003B1; by regulating PHD3 stability, thereby playing important roles in the cellular response to hypoxia (<xref rid="b19-or-33-03-1185" ref-type="bibr">19</xref>). As Siah1 possesses a high similarity with Siah2, whether it plays an equivalent role under hypoxic conditions is still unknown. Our results indicate that Siah1 is involved in the regulation of HIF-1&#x003B1; in human glioma and plays a similar role to that of Siah2.</p>
<p>In conclusion, the present study found that Siah1 is upregulated in human glioma tissues, and plays important roles in glioma cell migration and invasion in the cellular response to hypoxia. To our knowledge, this is the first study to focus on the role of Siah1 in glioma cells. The present study revealed the function of Siah1 in glioma cells and indicates that Siah1 may be a potential molecular target for the treatment of glioma based on the interference of the Siah1-PHD3-HIF-1&#x003B1; signaling pathway.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was supported by the National Natural Science Foundation of China (nos. 81201264 and 81272777), and the China Postdoctoral Science Foundation.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-or-33-03-1185"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>PY</given-names></name><name><surname>Kesari</surname><given-names>S</given-names></name></person-group><article-title>Malignant gliomas in adults</article-title><source>N Engl J Med</source><volume>5</volume><fpage>492</fpage><lpage>507</lpage><year>2008</year><pub-id pub-id-type="doi">10.1056/NEJMra0708126</pub-id></element-citation></ref>
<ref id="b2-or-33-03-1185"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Butowski</surname><given-names>N</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name></person-group><article-title>Recent advances in therapy for glioblastoma</article-title><source>Arch Neurol</source><volume>67</volume><fpage>279</fpage><lpage>283</lpage><year>2010</year><pub-id pub-id-type="doi">10.1001/archneurol.2010.5</pub-id><pub-id pub-id-type="pmid">20212224</pub-id></element-citation></ref>
<ref id="b3-or-33-03-1185"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>B</given-names></name><name><surname>Khwaja</surname><given-names>FW</given-names></name><name><surname>Severson</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis</article-title><source>Neuro Oncol</source><volume>7</volume><fpage>134</fpage><lpage>153</lpage><year>2005</year><pub-id pub-id-type="doi">10.1215/S1152851704001115</pub-id><pub-id pub-id-type="pmid">15831232</pub-id><pub-id pub-id-type="pmcid">1871894</pub-id></element-citation></ref>
<ref id="b4-or-33-03-1185"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vordermark</surname><given-names>D</given-names></name></person-group><article-title>Significance of hypoxia in malignant glioma. Re: Evans et al Hypoxia is important in the biology and aggression of human glial brain tumors</article-title><source>Clin Cancer Res</source><volume>11</volume><fpage>3966</fpage><lpage>3968</lpage><year>2005</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-0097</pub-id></element-citation></ref>
<ref id="b5-or-33-03-1185"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>SM</given-names></name><name><surname>Judy</surname><given-names>KD</given-names></name><name><surname>Dunphy</surname><given-names>I</given-names></name><etal/></person-group><article-title>Hypoxia is important in the biology and aggression of human glial brain tumors</article-title><source>Clin Cancer Res</source><volume>10</volume><fpage>8177</fpage><lpage>8184</lpage><year>2004</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1081</pub-id><pub-id pub-id-type="pmid">15623592</pub-id></element-citation></ref>
<ref id="b6-or-33-03-1185"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>J</given-names></name><name><surname>Hahnel</surname><given-names>A</given-names></name><name><surname>Wichmann</surname><given-names>H</given-names></name><etal/></person-group><article-title>HIF-1&#x003B1; inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression</article-title><source>BMC Cancer</source><volume>10</volume><fpage>605</fpage><year>2010</year><pub-id pub-id-type="doi">10.1186/1471-2407-10-605</pub-id></element-citation></ref>
<ref id="b7-or-33-03-1185"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>WR</given-names></name><name><surname>Hay</surname><given-names>MP</given-names></name></person-group><article-title>Targeting hypoxia in cancer therapy</article-title><source>Nat Rev Cancer</source><volume>11</volume><fpage>393</fpage><lpage>410</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/nrc3064</pub-id><pub-id pub-id-type="pmid">21606941</pub-id></element-citation></ref>
<ref id="b8-or-33-03-1185"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipkowitz</surname><given-names>S</given-names></name><name><surname>Weissman</surname><given-names>AM</given-names></name></person-group><article-title>RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis</article-title><source>Nat Rev Cancer</source><volume>11</volume><fpage>629</fpage><lpage>643</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/nrc3120</pub-id><pub-id pub-id-type="pmid">21863050</pub-id><pub-id pub-id-type="pmcid">3542975</pub-id></element-citation></ref>
<ref id="b9-or-33-03-1185"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jans</surname><given-names>J</given-names></name><name><surname>van Dijk</surname><given-names>JH</given-names></name><name><surname>van Schelven</surname><given-names>S</given-names></name><etal/></person-group><article-title>Expression and localization of hypoxia proteins in prostate cancer: prognostic implications after radical prostatectomy</article-title><source>Urology</source><volume>75</volume><fpage>786</fpage><lpage>792</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.urology.2009.08.024</pub-id></element-citation></ref>
<ref id="b10-or-33-03-1185"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CC</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gilkes</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis</article-title><source>J Mol Med</source><volume>90</volume><fpage>803</fpage><lpage>815</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s00109-011-0855-y</pub-id><pub-id pub-id-type="pmid">22231744</pub-id><pub-id pub-id-type="pmcid">3437551</pub-id></element-citation></ref>
<ref id="b11-or-33-03-1185"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>ML</given-names></name><name><surname>Hsu</surname><given-names>CY</given-names></name><name><surname>Chao</surname><given-names>KS</given-names></name></person-group><article-title>Inhibition of hypoxia inducible factor 1&#x003B1; causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells</article-title><source>Int J Radiat Oncol Biol Phys</source><volume>55</volume><fpage>1027</fpage><lpage>1036</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0360-3016(02)04507-8</pub-id><pub-id pub-id-type="pmid">12605983</pub-id></element-citation></ref>
<ref id="b12-or-33-03-1185"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hypoxia-inducible factor-1&#x003B1; blocks differentiation of malignant gliomas</article-title><source>FEBS J</source><volume>276</volume><fpage>7291</fpage><lpage>7304</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07441.x</pub-id><pub-id pub-id-type="pmid">19912340</pub-id></element-citation></ref>
<ref id="b13-or-33-03-1185"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>DL</given-names></name><name><surname>Flynn</surname><given-names>JR</given-names></name><name><surname>Ragel</surname><given-names>BT</given-names></name><etal/></person-group><article-title>Silencing of HIF-1&#x003B1; by RNA interference in human glioma cells in vitro and in vivo</article-title><source>Methods Mol Biol</source><volume>487</volume><fpage>283</fpage><lpage>301</lpage><year>2009</year></element-citation></ref>
<ref id="b14-or-33-03-1185"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carthew</surname><given-names>RW</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name></person-group><article-title>seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye</article-title><source>Cell</source><volume>63</volume><fpage>561</fpage><lpage>577</lpage><year>1990</year><pub-id pub-id-type="doi">10.1016/0092-8674(90)90452-K</pub-id><pub-id pub-id-type="pmid">2146028</pub-id></element-citation></ref>
<ref id="b15-or-33-03-1185"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Chung</surname><given-names>YL</given-names></name><name><surname>Glover</surname><given-names>T</given-names></name><etal/></person-group><article-title>Characterization of human homologs of the Drosophila seven in absentia (sina) gene</article-title><source>Genomics</source><volume>46</volume><fpage>103</fpage><lpage>111</lpage><year>1997</year><pub-id pub-id-type="doi">10.1006/geno.1997.4997</pub-id><pub-id pub-id-type="pmid">9403064</pub-id></element-citation></ref>
<ref id="b16-or-33-03-1185"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habelhah</surname><given-names>H</given-names></name><name><surname>Frew</surname><given-names>IJ</given-names></name><name><surname>Laine</surname><given-names>A</given-names></name><etal/></person-group><article-title>Stress-induced decrease in TRAF2 stability is mediated by Siah2</article-title><source>EMBO J</source><volume>21</volume><fpage>5756</fpage><lpage>5765</lpage><year>2002</year><pub-id pub-id-type="doi">10.1093/emboj/cdf576</pub-id><pub-id pub-id-type="pmid">12411493</pub-id><pub-id pub-id-type="pmcid">131073</pub-id></element-citation></ref>
<ref id="b17-or-33-03-1185"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habelhah</surname><given-names>H</given-names></name><name><surname>Laine</surname><given-names>A</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><etal/></person-group><article-title>Regulation of 2-oxoglutarate (&#x003B1;-ketoglutarate) dehydrogenase stability by the RING finger ubiquitin ligase Siah</article-title><source>J Biol Chem</source><volume>279</volume><fpage>53782</fpage><lpage>53788</lpage><year>2004</year><pub-id pub-id-type="doi">10.1074/jbc.M410315200</pub-id><pub-id pub-id-type="pmid">15466852</pub-id></element-citation></ref>
<ref id="b18-or-33-03-1185"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzawa</surname><given-names>SI</given-names></name><name><surname>Reed</surname><given-names>JC</given-names></name></person-group><article-title>Siah-1, SIP, and Ebi collaborate in a novel pathway for &#x003B2;-catenin degradation linked to p53 responses</article-title><source>Mol Cell</source><volume>7</volume><fpage>915</fpage><lpage>926</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S1097-2765(01)00242-8</pub-id><pub-id pub-id-type="pmid">11389839</pub-id></element-citation></ref>
<ref id="b19-or-33-03-1185"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Frew</surname><given-names>IJ</given-names></name><name><surname>Hagensen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Siah2 regulates stability of prolyl-hydroxylases, controls HIF1&#x003B1; abundance, and modulates physiological responses to hypoxia</article-title><source>Cell</source><volume>117</volume><fpage>941</fpage><lpage>952</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.cell.2004.06.001</pub-id><pub-id pub-id-type="pmid">15210114</pub-id></element-citation></ref>
<ref id="b20-or-33-03-1185"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Carthew</surname><given-names>RW</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><article-title>Proteasomal regulation of nuclear receptor corepressor-mediated repression</article-title><source>Genes Dev</source><volume>12</volume><fpage>1775</fpage><lpage>1780</lpage><year>1998</year><pub-id pub-id-type="doi">10.1101/gad.12.12.1775</pub-id><pub-id pub-id-type="pmid">9637679</pub-id><pub-id pub-id-type="pmcid">316907</pub-id></element-citation></ref>
<ref id="b21-or-33-03-1185"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Satoh</surname><given-names>S</given-names></name><name><surname>Okabe</surname><given-names>H</given-names></name><etal/></person-group><article-title>SIAH1 inactivation correlates with tumor progression in hepatocellular carcinomas</article-title><source>Genes Chromosomes Cancer</source><volume>36</volume><fpage>283</fpage><lpage>291</lpage><year>2003</year><pub-id pub-id-type="doi">10.1002/gcc.10170</pub-id><pub-id pub-id-type="pmid">12557228</pub-id></element-citation></ref>
<ref id="b22-or-33-03-1185"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>YY</given-names></name><name><surname>Yang</surname><given-names>ZQ</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><etal/></person-group><article-title>The expression of SIAH1 is downregulated and associated with Bim and apoptosis in human breast cancer tissues and cells</article-title><source>Mol Carcinog</source><volume>49</volume><fpage>440</fpage><lpage>449</lpage><year>2010</year><pub-id pub-id-type="pmid">20082325</pub-id></element-citation></ref>
<ref id="b23-or-33-03-1185"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Wakisaka</surname><given-names>N</given-names></name><etal/></person-group><article-title>Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma</article-title><source>Cancer Lett</source><volume>331</volume><fpage>52</fpage><lpage>57</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.canlet.2012.12.002</pub-id></element-citation></ref>
<ref id="b24-or-33-03-1185"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>CacyBP/SIP protein is important for the proliferation of human glioma cells</article-title><source>IUBMB Life</source><volume>66</volume><fpage>286</fpage><lpage>291</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/iub.1263</pub-id><pub-id pub-id-type="pmid">24740456</pub-id></element-citation></ref>
<ref id="b25-or-33-03-1185"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name><name><surname>Tian</surname><given-names>RF</given-names></name><etal/></person-group><article-title>The expression and significance of HIF-1&#x003B1; and GLUT-3 in glioma</article-title><source>Brain Res</source><volume>1304</volume><fpage>149</fpage><lpage>154</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.083</pub-id><pub-id pub-id-type="pmid">19782666</pub-id></element-citation></ref>
<ref id="b26-or-33-03-1185"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia</article-title><source>Biochem Biophys Res Commun</source><volume>415</volume><fpage>348</fpage><lpage>354</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.10.065</pub-id><pub-id pub-id-type="pmid">22037464</pub-id></element-citation></ref>
<ref id="b27-or-33-03-1185"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>NL</given-names></name><name><surname>Yang</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Phosphatidylinositol 3&#x02032;-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1&#x003B1; and vascular endothelial growth factor expression</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>300</volume><fpage>H2169</fpage><lpage>H2176</lpage><year>2011</year><pub-id pub-id-type="doi">10.1152/ajpheart.00970.2010</pub-id><pub-id pub-id-type="pmid">21357506</pub-id></element-citation></ref>
<ref id="b28-or-33-03-1185"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><etal/></person-group><article-title>Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><volume>247</volume><fpage>633</fpage><lpage>639</lpage><year>2009</year><pub-id pub-id-type="doi">10.1007/s00417-008-1031-0</pub-id><pub-id pub-id-type="pmid">19165496</pub-id></element-citation></ref>
<ref id="b29-or-33-03-1185"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>YC</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><article-title>Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1</article-title><source>Mol Cell Biol</source><volume>27</volume><fpage>7381</fpage><lpage>7393</lpage><year>2007</year><pub-id pub-id-type="doi">10.1128/MCB.00440-07</pub-id><pub-id pub-id-type="pmid">17785433</pub-id><pub-id pub-id-type="pmcid">2169056</pub-id></element-citation></ref>
<ref id="b30-or-33-03-1185"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>G</given-names></name><name><surname>Nanduri</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Induction of HIF-1&#x003B1; expression by intermittent hypoxia: involvement of NADPH oxidase, Ca<sup>2+</sup> signaling, prolyl hydroxylases, and mTOR</article-title><source>J Cell Physiol</source><volume>217</volume><fpage>674</fpage><lpage>685</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/jcp.21537</pub-id><pub-id pub-id-type="pmid">18651560</pub-id><pub-id pub-id-type="pmcid">2696817</pub-id></element-citation></ref>
<ref id="b31-or-33-03-1185"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Geranylgeranyltransferase I regulates HIF-1&#x003B1; promoting glioblastoma cell migration and invasion</article-title><source>J Neurooncol</source><volume>112</volume><fpage>365</fpage><lpage>374</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s11060-013-1081-y</pub-id><pub-id pub-id-type="pmid">23475391</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-or-33-03-1185" position="float">
<label>Figure 1</label>
<caption>
<p>Siah1 expression is increased in human glioma tissues. Total proteins isolated from non-tumorous brain and glioma tissues were subjected to western blotting for assessment of Siah1. (A) Representative blots of Siah1 from non-tumorous brain and human glioma tissues, &#x003B2;-actin served as an internal control. (B) Statistical analysis of the relative level of Siah1 in non-tumorous brain tissues (n=6), low-grade glioma tissues (n=6) and high-grade glioma tissues (n=12), <sup>*</sup>P&lt;0.05, <sup>**</sup>P&lt;0.01.</p></caption>
<graphic xlink:href="OR-33-03-1185-g00.gif"/></fig>
<fig id="f2-or-33-03-1185" position="float">
<label>Figure 2</label>
<caption>
<p>Downregulation of Siah1 inhibits glioma cell migration and invasion under hypoxia. U251 cells stably expressing the scramble or shSiah1 were subjected to a wound healing assay for migration and a Transwell assay for assessment of invasion. (A) Silencing efficiency of Siah1 shRNAs was examined by western blotting. (B) Fluorescence and western blotting confirmed that the stable cell lines expressed the scramble or shSiah1. (C and D) Wound healing assay showed that inhibition of Siah1 reduced glioma cell migration compared with the control. Scale bar, 100 &#x003BC;m. <sup>**</sup>P&lt;0.01. (E and F) Silencing of Siah1 decreased glioma cell invasion. Scale bar, 100 &#x003BC;m. <sup>*</sup>P&lt;0.05.</p></caption>
<graphic xlink:href="OR-33-03-1185-g01.gif"/></fig>
<fig id="f3-or-33-03-1185" position="float">
<label>Figure 3</label>
<caption>
<p>Overexpression of Siah1 promotes glioma cell migration and invasion under hypoxia. U251 cells stably expressing GFP or GFP-Siah1 were subjected to a wound healing assay for assessment of migration and a Transwell assay for assessment of invasion. (A) Stable cell lines expressing GFP or GFP-Siah1. (B) Confirmation of the expression by western blotting. (C and D) Wound healing assay showed that overexpression of Siah1 promoted glioma cell migration compared with the control. Scale bar, 100 &#x003BC;m. <sup>*</sup>P&lt;0.05, <sup>**</sup>P&lt;0.01. (E and F) Overexpression of Siah1 reinforced glioma cell invasion. Scale bar, 100 &#x003BC;m. <sup>*</sup>P&lt;0.05.</p></caption>
<graphic xlink:href="OR-33-03-1185-g02.gif"/></fig>
<fig id="f4-or-33-03-1185" position="float">
<label>Figure 4</label>
<caption>
<p>Siah1 induces HIF-1&#x003B1; by promoting the degradation of PHD3 in human glioma cells under hypoxia. The cell lines with loss-of and gain-of Siah1 were treated under hypoxia. The cells were then harvested at the indicated time points and were lysed in lysis buffer. The lysates were subjected to western blotting for detection of HIF-1&#x003B1; and PHD3. (A and C) Representative blots of PHD3 and HIF-1&#x003B1;. (B and D) Statistical analyses of the relative protein levels of HIF-1&#x003B1; and PHD3. <sup>*</sup>P&lt;0.05, <sup>**</sup>P&lt;0.01.</p></caption>
<graphic xlink:href="OR-33-03-1185-g03.gif"/></fig></floats-group></article>
